• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环境、风险与健康危害:对英国使用减少伤害服务的人群中非法使用合成代谢类固醇情况的定性调查

Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK.

作者信息

Kimergård Andreas, McVeigh Jim

机构信息

Addictions Department, National Addiction Centre, Institute of Psychiatry, King's College London, London, UK Centre for Public Health, Liverpool John Moores University, Liverpool, UK.

Centre for Public Health, Liverpool John Moores University, Liverpool, UK.

出版信息

BMJ Open. 2014 Jun 4;4(6):e005275. doi: 10.1136/bmjopen-2014-005275.

DOI:10.1136/bmjopen-2014-005275
PMID:24898090
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4054627/
Abstract

OBJECTIVES

The illicit use of anabolic steroids among the gym population continues to rise, along with the number of steroid using clients attending harm reduction services in the UK. This presents serious challenges to public health. Study objectives were to account for the experiences of anabolic steroid users and investigate how 'risk environments' produce harm.

METHODS

Qualitative face-to-face interviews with 24 users of anabolic steroids engaged with harm reduction services in the UK.

RESULTS

Body satisfaction was an important factor when deciding to start the use of anabolic steroids. Many users were unaware of the potential dangers of using drugs from the illicit market, whereas some had adopted a range of strategies to negotiate the hazards relating to the use of adulterated products, including self-experimentation to gauge the perceived efficacy and unwanted effects of these drugs. Viewpoints, first-hand anecdotes, norms and practices among groups of steroid users created boundaries of 'sensible' drug use, but also promoted practices that may increase the chance of harms occurring. Established users encouraged young users to go to harm reduction services but, at the same time, promoted risky injecting practices in the belief that this would enhance the efficacy of anabolic steroids.

CONCLUSIONS

Current steroid-related viewpoints and practices contribute to the risk environment surrounding the use of these drugs and may undermine the goal of current public health strategies including harm reduction interventions. The level of harms among anabolic steroid users are determined by multiple and intertwining factors, in addition to the harms caused by the pharmacological action or injury and illness associated with incorrect injecting techniques.

摘要

目标

在健身人群中,合成代谢类固醇的非法使用呈上升趋势,同时在英国,使用类固醇并寻求减少伤害服务的客户数量也在增加。这给公共卫生带来了严峻挑战。研究目标是了解合成代谢类固醇使用者的经历,并调查“风险环境”是如何造成伤害的。

方法

对24名在英国接受减少伤害服务的合成代谢类固醇使用者进行了定性面对面访谈。

结果

身体满意度是决定开始使用合成代谢类固醇的一个重要因素。许多使用者并未意识到从非法市场获取药物的潜在危险,而有些人则采取了一系列策略来应对使用掺假产品带来的风险,包括自我试验以评估这些药物的预期功效和不良影响。类固醇使用者群体中的观点、第一手轶事、规范和做法划定了“合理”用药的界限,但也助长了一些可能增加伤害发生几率的行为。有经验的使用者鼓励年轻使用者去接受减少伤害服务,但同时又宣扬危险的注射行为,认为这样能提高合成代谢类固醇的功效。

结论

当前与类固醇相关的观点和做法加剧了围绕这些药物使用的风险环境,可能会破坏包括减少伤害干预措施在内的当前公共卫生战略目标。合成代谢类固醇使用者所遭受伤害的程度是由多种相互交织的因素决定的,除了药物作用、不正确注射技术导致的伤害和疾病所造成的危害之外。

相似文献

1
Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK.环境、风险与健康危害:对英国使用减少伤害服务的人群中非法使用合成代谢类固醇情况的定性调查
BMJ Open. 2014 Jun 4;4(6):e005275. doi: 10.1136/bmjopen-2014-005275.
2
Variability and dilemmas in harm reduction for anabolic steroid users in the UK: a multi-area interview study.英国合成代谢类固醇使用者减少伤害措施中的变异性与困境:一项多地区访谈研究
Harm Reduct J. 2014 Jul 2;11:19. doi: 10.1186/1477-7517-11-19.
3
The risk environment of anabolic-androgenic steroid users in the UK: Examining motivations, practices and accounts of use.英国合成代谢雄激素类固醇使用者的风险环境:探究使用动机、行为及相关描述。
Int J Drug Policy. 2017 Feb;40:35-43. doi: 10.1016/j.drugpo.2016.11.005. Epub 2016 Dec 7.
4
Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.使用提高成绩和增强形象药物的男性中的注射风险行为及相关危害。
Drug Alcohol Rev. 2008 Nov;27(6):679-86. doi: 10.1080/09595230802392568.
5
An exploratory study of image and performance enhancement drug use in a male British South Asian community.对英国南亚裔男性群体中使用形象与性能增强药物的探索性研究。
Int J Drug Policy. 2015 Sep;26(9):860-7. doi: 10.1016/j.drugpo.2015.03.002. Epub 2015 Mar 14.
6
Expanding conceptualizations of harm reduction: results from a qualitative community-based participatory research study with people who inject drugs.拓展减少伤害的概念:一项基于社区的定性参与式研究结果,研究对象为注射吸毒者。
Harm Reduct J. 2017 May 12;14(1):18. doi: 10.1186/s12954-017-0145-2.
7
Safety strategies and harm reduction for methamphetamine users in the era of fentanyl contamination: A qualitative analysis.芬太尼污染时代美沙酮使用者的安全策略和减少伤害:定性分析。
Int J Drug Policy. 2024 Jun;128:104456. doi: 10.1016/j.drugpo.2024.104456. Epub 2024 May 17.
8
Key stakeholders' perspectives of illicit drug use and associated harms in the Northern Territory of Australia.关键利益攸关方对澳大利亚北部地区非法药物使用及其相关危害的看法。
Harm Reduct J. 2024 Sep 20;21(1):174. doi: 10.1186/s12954-024-01092-w.
9
The risk environments of people who use drugs accessing two harm reduction centers in Tehran, Iran: A qualitative study.伊朗德黑兰的两家减少伤害中心中使用毒品者的风险环境:一项定性研究。
Int J Drug Policy. 2019 Jan;63:90-96. doi: 10.1016/j.drugpo.2018.11.013. Epub 2018 Dec 2.
10
Physical appearance concerns are uniquely associated with the severity of steroid dependence and depression in anabolic-androgenic steroid users.身体外貌的担忧与合成代谢类固醇使用者的类固醇依赖和抑郁的严重程度有着独特的关联。
Drug Alcohol Rev. 2018 Jul;37(5):664-670. doi: 10.1111/dar.12688. Epub 2018 Feb 27.

引用本文的文献

1
Managing risks and harms associated with the use of anabolic steroids: a qualitative study.管理与使用合成代谢类固醇相关的风险和危害:一项定性研究。
Harm Reduct J. 2025 Jul 28;22(1):129. doi: 10.1186/s12954-025-01269-x.
2
Community pharmacy's role in dispensing androgens and supporting harm reduction amid current policy dilemmas.社区药房在当前政策困境下分发雄激素及支持减少危害方面的作用。
Subst Abuse Treat Prev Policy. 2025 Jan 18;20(1):2. doi: 10.1186/s13011-025-00636-y.
3
Anabolic-Androgenic Steroid Use: Patterns of Use among a National Sample of Canadian Adolescents and Young Adults.合成代谢雄激素类固醇的使用:加拿大青少年和青年全国样本中的使用模式。
Perform Enhanc Health. 2023 Feb;11(1). doi: 10.1016/j.peh.2022.100241. Epub 2022 Nov 20.
4
Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study.男性使用合成代谢雄激素类固醇的健康服务参与度、副作用和担忧:一项挪威的横断面研究。
Subst Abuse Treat Prev Policy. 2023 Apr 3;18(1):19. doi: 10.1186/s13011-023-00528-z.
5
Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis.寻求医生支持的 anabolic 类固醇使用者的流行率:系统评价和荟萃分析。
BMJ Open. 2022 Jul 4;12(7):e056445. doi: 10.1136/bmjopen-2021-056445.
6
No association between psychiatric symptoms and doses of anabolic steroids in a cohort of male and female bodybuilders.在一组男性和女性健美运动员中,精神症状与合成代谢类固醇剂量之间没有关联。
Drug Test Anal. 2022 Jun;14(6):1079-1088. doi: 10.1002/dta.3230. Epub 2022 Feb 21.
7
Treatments for people who use anabolic androgenic steroids: a scoping review.使用合成代谢雄激素类药物者的治疗方法:范围综述。
Harm Reduct J. 2019 Dec 30;16(1):75. doi: 10.1186/s12954-019-0343-1.
8
Anabolic steroids among resistance training practitioners.抗阻力训练者使用合成代谢类固醇。
PLoS One. 2019 Oct 16;14(10):e0223384. doi: 10.1371/journal.pone.0223384. eCollection 2019.
9
Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access.支持使用合成代谢雄激素类固醇者的相关措施:一项系统范围的探索性综述,了解他们的需求和可获得性。
BMC Public Health. 2019 Jul 31;19(1):1024. doi: 10.1186/s12889-019-7288-x.
10
Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires.接受健康相关信息的合成代谢-雄激素类固醇使用者;健康问题、戒断动机和治疗愿望。
Subst Abuse Treat Prev Policy. 2019 May 16;14(1):20. doi: 10.1186/s13011-019-0206-5.

本文引用的文献

1
Online marketing of synthetic peptide hormones: poor manufacturing, user safety, and challenges to public health.合成肽激素的网络营销:生产不佳、用户安全及对公众健康的挑战。
Drug Test Anal. 2014 Apr;6(4):396-8. doi: 10.1002/dta.1636. Epub 2014 Mar 17.
2
Is the breast cancer drug tamoxifen being sold as a bodybuilding dietary supplement?治疗乳腺癌的药物他莫昔芬是否被作为一种健身膳食补充剂出售?
BMJ. 2014 Feb 13;348:g1476. doi: 10.1136/bmj.g1476.
3
Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement.提高成绩药物对健康的不良后果:美国内分泌学会科学声明
Endocr Rev. 2014 Jun;35(3):341-75. doi: 10.1210/er.2013-1058. Epub 2013 Dec 17.
4
Moral disengagement and associated processes in performance-enhancing drug use: a national qualitative investigation.道德脱离及其在使用兴奋剂行为中的相关作用:全国定性研究。
J Sports Sci. 2014;32(9):836-44. doi: 10.1080/02640414.2013.862842. Epub 2014 Jan 10.
5
Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study.注射影像和效能增强药物的男性中艾滋病毒、乙型肝炎和丙型肝炎感染的流行情况和危险因素:一项横断面研究。
BMJ Open. 2013 Sep 12;3(9):e003207. doi: 10.1136/bmjopen-2013-003207.
6
Weightlifting's risky new trend: a case series of 41 insulin users.举重运动中危险的新趋势:41例胰岛素使用者的病例系列报道
Curr Sports Med Rep. 2012 Jul-Aug;11(4):176-9. doi: 10.1249/JSR.0b013e31825da97f.
7
Elephant in the room? The methodological implications for public health research of performance-enhancing drugs derived from the illicit market.房间里的大象?非法市场衍生的兴奋剂对公共卫生研究方法学的影响。
Drug Test Anal. 2009 Jul;1(7):323-6. doi: 10.1002/dta.74.
8
Risk environments and drug harms: a social science for harm reduction approach.风险环境与药物危害:一种减少危害方法的社会科学
Int J Drug Policy. 2009 May;20(3):193-201. doi: 10.1016/j.drugpo.2008.10.003. Epub 2009 Jan 14.
9
The development of multiple drug use among anabolic-androgenic steroid users: six subjective case reports.合成代谢雄激素类固醇使用者中多药联用情况的发展:六例主观病例报告
Subst Abuse Treat Prev Policy. 2008 Nov 28;3:24. doi: 10.1186/1747-597X-3-24.
10
Analysing and presenting qualitative data.分析和呈现定性数据。
Br Dent J. 2008 Apr 26;204(8):429-32. doi: 10.1038/sj.bdj.2008.292.